Get the Stockscreener App
177.87
0.31%
0.55
After Hours:
177.87
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $177.87, with a volume of 1.33M.
It is up +0.31% in the last 24 hours and up +1.44% over the past month.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
See More
Previous Close:
$177.32
Open:
$177.85
24h Volume:
1.33M
Relative Volume:
0.84
Market Cap:
$9.29B
Revenue:
$1.53B
Net Income/Loss:
$207.70M
P/E Ratio:
-64.13
EPS:
-2.7734
Net Cash Flow:
$193.10M
1W Performance:
-0.46%
1M Performance:
+1.44%
6M Performance:
+20.55%
1Y Performance:
+6.76%
1-Day Range:
$176.94
$178.21
1-Week Range:
$176.68
$178.77
52-Week Range:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
177.87 | 9.26B | 1.53B | 207.70M | 193.10M | -2.7734 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Quinn Emanuel Disqualified from Masimo Board Fight with Founder - Bloomberg Law News
Masimo Corp Stock: Innovative Medical Tech Leader with Strong Growth Potential for North American In - ad-hoc-news.de
Assenagon Asset Management S.A. Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal - ad-hoc-news.de
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
The Vanguard Group discloses 0 shares in Masimo Corp (NASDAQ: MASI) - Stock Titan
Masimo downgraded to Market Perform from Outperform at Raymond James - TipRanks
Masimo (NASDAQ:MASI) Rating Lowered to Market Perform at Raymond James Financial - MarketBeat
Raymond James downgrades Masimo stock rating on Danaher deal By Investing.com - Investing.com India
Masimo Corporation $MASI Shares Sold by JPMorgan Chase & Co. - MarketBeat
Raymond James downgrades Masimo stock rating on Danaher deal - Investing.com
Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
MASI PE Ratio & Valuation, Is MASI Overvalued - Intellectia AI
Tudor Investment Corp ET AL Buys New Holdings in Masimo Corporation $MASI - MarketBeat
Masimo MightySat Medical Fingertip Pulse Oximeter: Precision Health Monitoring for Home and Clinical - AD HOC NEWS
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Masimo (NASDAQ:MASI) Reaches New 12-Month HighTime to Buy? - MarketBeat
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition - Yahoo Finance
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition - The Motley Fool
Masimo's Patient Monitoring Innovations Drive Growth in Wearable Health Tech for DACH Markets - AD HOC NEWS
Masimo's Latest Health Monitoring Receivers Advance Wearable Audio Integration for DACH Consumers - AD HOC NEWS
MASI Technical Analysis & Stock Price Forecast - Intellectia AI
Apple fends off bid for new Apple Watch import ban at US trade tribunal - Reuters
Masimo (NASDAQ:MASI) Upgraded at Wells Fargo & Company - MarketBeat
Apple Took Masimo IP But No Remedy Warranted, Judge Says - Law360
Danaher to buy Masimo (MASI) for $180 a share; $305M breakup fee - Stock Titan
Masimo (NASDAQ:MASI) Sets New 52-Week HighShould You Buy? - MarketBeat
Masimo Corporation stock hits 52-week high at $175.91 - Investing.com
Masimo Corporation stock hits 52-week high at $175.91 By Investing.com - Investing.com Canada
Masimo (NASDAQ:MASI) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Danaher to acquire Irvine-based Masimo - Irvine Standard
Masimo (MASI) CFO exercises RSUs, retains shares after tax withholding - Stock Titan
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders? – Company Announcement - Financial Times
MASIMO (MASI) CEO Szyman exercises RSUs, withholds shares to cover tax - Stock Titan
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement - Yahoo Finance
Masimo Corporation $MASI Shares Purchased by Squarepoint Ops LLC - MarketBeat
Onex Canada Asset Management Inc. Has $4.12 Million Stake in Masimo Corporation $MASI - MarketBeat
Danaher Corp to acquire Masimo for $9.9B - respiratory-therapy.com
Politan-linked funds structure MASIMO (MASI) forward sales over 273,550 shares - Stock Titan
12,025 Shares in Masimo Corporation $MASI Bought by Quantitative Investment Management LLC - MarketBeat
Danaher Corp. Stock (ISIN: US2358511028) Slides Amid Masimo Acquisition Scrutiny and Conservative Gu - AD HOC NEWS
Danaher Corp Stock (DHR) Moved Down by 3.55% on Mar 12: Drivers Behind the Movement - TradingKey
MASI SEC FilingsMasimo Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Schroder Investment Management Group Has $48.12 Million Holdings in Masimo Corporation $MASI - MarketBeat
Masimo (MASI) Chief Commercial Officer granted 8,550 RSUs in new Form 4 - Stock Titan
Masimo (MASI) grants Chief Marketing Officer 6,128 RSUs vesting over four years - Stock Titan
Masimo (MASI) grants 5,985 restricted stock units to Chief HR Officer - Stock Titan
Masimo (MASI) awards EVP of Operations 6,840 restricted stock units - Stock Titan
Masimo (NASDAQ: MASI) CFO gets 17,671 RSUs vesting over 4 years - Stock Titan
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Masimo Corp Stock (MASI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Young Micah W | EVP & Chief Financial Officer |
Mar 11 '26 |
Option Exercise |
0.00 |
873 |
0 |
26,127 |
| Szyman Catherine M. | CEO |
Feb 12 '26 |
Option Exercise |
132.96 |
11,141 |
1,481,307 |
11,141 |
| Sampath Anand | EVP, Ops & Clinical Research |
Jan 28 '26 |
Option Exercise |
37.84 |
30,000 |
1,135,200 |
59,589 |
| Sampath Anand | EVP, Ops & Clinical Research |
Jan 28 '26 |
Sale |
136.81 |
18,680 |
2,555,570 |
40,909 |
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):